This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a s1 receptor agonist that also has NMDA antagonist activity.
申请公布号
WO2010033801(A1)
申请公布日期
2010.03.25
申请号
WO2009US57476
申请日期
2009.09.18
申请人
CONCERT PHARMACEUTICALS INC.;GRAHAM, PHILIP B.;SILVERMAN, I. ROBERT
